Unsaturated Fatty Acid for Preventive Cardiovascular Disease

Obesity and metabolic syndrome have lipids intake problems including Monounsaturated Fatty Acid (MUFA) and Polyunsaturated Fatty Acid (PUFA). For decreasing the Atherosclerotic Cardiovascular Disease (ASCVD) risk, to replace of Saturated Fatty Acid (SFA) with PUFA and/or MUFA would be adequate. Finn Study including 2200 cases showed that Odd Ratio (OR) for obesity was SFAs: 1.28, MUFAs: 1.38, PUFAs: 0.70, Linoleic Acid (LA): 0.67 and DHA: 0.75. In Norwegian study with 3706 cases, higher LA levels were significantly associated with lower values of LDL-C, triglycerides, blood glucose, body mass index, blood pressure and eGFR. These current data are useful for practice.

This is an open-access article distributed under the terms of the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.